Protiveris, Inc. Installs VeriScan(TM) Biosensor System And Begins Collaboration With University Of Genoa 
10/19/2005 5:12:59 PM

ROCKVILLE, Md., March 10 /PRNewswire/ -- Protiveris, Inc., a bio- nanotechnology company commercializing microcantilever technologies to facilitate biomolecular research, today announced that it has successfully completed installation of the VeriScan(TM) 3000 biosensor system at the University of Genoa, Italy.

Dr. Roberto Raiteri, in the University's Department of Biophysical and Electronic Engineering, will lead a collaborative effort to further biosensor science and technology using Protiveris's microcantilever-based products.

"We are very excited to have our products at the University of Genoa with Dr. Raiteri, a recognized leader in biosensor research," commented Robert Menzi, Chief Operating Officer at Protiveris. "We are quite confident that this collaboration will further establish microcantilever technology applications in biological discovery."

"It is a unique opportunity for us to collaborate with Protiveris and access their state-of-the-art cantilever-based sensor technology," said Dr. Raiteri, University of Genoa. "We believe this collaboration will boost our research productivity on the development of new genomic and proteomic bio- assays."

The VeriScan 3000 protein biochip and optical reader utilize arrays of microcantilevers with customizable surfaces to measure, label-free and in real-time, multiplex and distinct biomolecular interactions. Protiveris is currently installing this system in forward-looking research facilities in the United States and Europe.

About Protiveris, Inc.

Protiveris is committed to establishing the standard of performance for proteomic research tools. The VeriScan(TM) 3000 bench-top biochip system measures and analyzes biomolecular and chemical interactions to enable more efficient and accurate research outcomes. The biochip utilizes arrays of microcantilevers with customizable surfaces to detect interactions between proteins, antibodies, antigens, or DNA. This label-free system provides researchers with the ability to create high content assays that deliver real time data. More information about Protiveris, their technology, products, and services can be found at the company's web site at

About DIBE, University of Genoa

The Department of Biophysical and Electronic Engineering (DIBE) at the University of Genoa is composed of research groups with focus ranging from Microelectronics to Bioengineering and Nanotechnology. The Neuroengineering and Bionanotechnology (NBT) group consists of a twelve person teaching staff, postdoctoral fellows and PhD students and is devoted to research in bioengineering, including the development of new SPM based technologies and methods to investigate biological surfaces at the nanometer level and the development of cantilever based biosensors. More information about the NBT group at the University of Genoa can be found at

Protiveris, Inc.

CONTACT: Robert Menzi, Chief Operating Officer of Protiveris, Inc.,+1-301-738-7800, or